Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO/DIS 10993-6:2024); German and English version prEN ISO 10993-6:2024

The standard DIN EN ISO 10993-6:2024, published by the German Institute for Standardization (DIN) on June 1, 2024, and effective from the same date, specifies the biological evaluation of medical devices. This standard, which is available in both German and English versions, focuses on the testing of local effects following implantation of medical devices, as outlined in ISO/DIS 10993-6:2024.

The primary objective of DIN EN ISO 10993-6:2024 is to provide a comprehensive framework for assessing the potential local tissue reactions that may occur after the implantation of medical devices. This includes evaluating the biocompatibility of materials used in medical devices, ensuring that they do not elicit adverse biological responses when in contact with living tissues. The standard outlines specific test methods and criteria for determining the local effects, such as inflammation, fibrosis, and other tissue responses, that may arise post-implantation.

By adhering to the guidelines set forth in DIN EN ISO 10993-6:2024, manufacturers and regulatory bodies can ensure that medical devices are safe for use in humans. The standard is particularly crucial for devices that are intended for long-term implantation, as it helps to minimize the risk of adverse tissue reactions and ensures the overall safety and efficacy of the device. The inclusion of both German and English versions facilitates international collaboration and compliance, making it easier for stakeholders worldwide to implement the standard effectively.